Morten S.
- Country
- Denmark
- Department
- Neurology, Physiotherapy and Occupational Therapy
Research Overview
- Long-term Safety and Tolerability of Tolebrutinib in Relapsing and Progressive Multiple Sclerosis: A Phase 3 Extension Study
- Phase 3 Extension Study on Long-term Safety and Tolerability of Tolebrutinib in Relapsing and Progressive Multiple Sclerosis
- Non-Inferiority Trial of Ocrelizumab Versus Rituximab in Active Multiple Sclerosis Patients
Data & Insights
Has run more than one trial at 6 of 158 partner sites.
Specializations
Neurology Research Focus
This investigator specializes in studying nervous system diseases, with particular emphasis on multiple sclerosis treatment approaches.
- Relapsing Multiple Sclerosis (RMS)
- Progressive Multiple Sclerosis (PMS)
The investigator conducts research on novel therapeutic interventions for multiple sclerosis management.
Therapeutic Expertise
Focuses on evaluating immunomodulatory treatments including advanced therapies targeting B-cell depletion.
- Long-term Treatment Safety
- Treatment Tolerability Assessment
- Comparative Treatment Efficacy
Specializes in investigating extended interval dosing strategies and treatment optimization.
Clinical Assessment Areas
Expertise in evaluating white matter lesions and conducting long-term safety monitoring.
- Disease Activity Monitoring
- Treatment Response Assessment
- Extended Duration Studies
Focuses on comprehensive evaluation of neurological disease progression and treatment outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.